Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function

被引:37
作者
Pall, Harpreft
Ziflenski, Julian
Jonas, Maureen M.
Dasilva, Deborah A.
Potvin, Kimberly M.
Yuan, Xiao-Wei
Huang, Qiuju
Freedman, Steven D.
机构
[1] Childrens Hosp, Harvard Med Sch, Div Pediat Gastroenterol, Boston, MA 02115 USA
[2] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada
[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA USA
关键词
D O I
10.1016/j.jpeds.2007.03.062
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To determine whether primary sclerosing cholangitis (PSC) in childhood is associated with abnormalities in cystic fibrosis transmembrane conductance regulator (CFTR). Study design Subjects with PSC diagnosed in childhood (n = 20) were recruited from Children's Hospital. Subjects had testing with sweat chloride concentration, nasal transmembrane potential difference, and extensive genetic analysis of the CFTR gene. Disease control subjects consisted of 14 patients with inflammatory bowel disease alone and no liver disease. t Tests were performed to determine statistical significance. Results In the PSC group, CFTR chloride channel function (Delta Chloride free + isoproterenol) was markedly diminished at -8.6 +/- 8.2 mV (reference range: -24.6 +/- 10.4 mV). In contrast, disease control subjects had normal function, at -17.8 +/- 9.7 mV (P = .008). Sweat chloride concentration in subjects with PSC was greater than in disease control subjects (20.8 +/- 3.4 mmol/L vs 12.0 +/- 1.6 mmol/L. P = .045). Comprehensive CFTR genotyping revealed that 5 of 19 (26.3%) subjects with PSC had a CFTR mutation or variant, compared with 6 of 14 (42.9%) disease control subjects. Conclusions There is a high prevalence of CFTR-mediated ion transport dysfunction in subjects with childhood PSC.
引用
收藏
页码:255 / 259
页数:5
相关论文
共 19 条
[11]  
KNOWLES MR, 1981, AM REV RESPIR DIS, V124, P484
[12]   The cholangiopathies: Disorders of biliary epithelia [J].
Lazaridis, KN ;
Strazzabosco, M ;
Larusso, NF .
GASTROENTEROLOGY, 2004, 127 (05) :1565-1577
[13]   Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients [J].
Muhlebach, MS ;
Stewart, PW ;
Leigh, MW ;
Noah, TL .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (01) :186-191
[14]   Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine [J].
Norkina, O ;
Burnett, TG ;
De Lisle, RC .
INFECTION AND IMMUNITY, 2004, 72 (10) :6040-6049
[15]   Decreased peroxisome proliferator activated receptor α is associated with bile duct injury in cystic fibrosis transmembrane conductance regulator-/- mice [J].
Pall, H ;
Zaman, MM ;
Andersson, C ;
Freedman, SD .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2006, 42 (03) :275-281
[16]   The diagnosis of cystic fibrosis: A consensus statement [J].
Rosenstein, BJ ;
Cutting, GR .
JOURNAL OF PEDIATRICS, 1998, 132 (04) :589-595
[17]   Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis [J].
Sheth, S ;
Shea, JC ;
Bishop, MD ;
Chopra, S ;
Regan, MM ;
Malmberg, E ;
Walker, C ;
Ricci, R ;
Tsui, LC ;
Durie, PR ;
Zielenski, J ;
Freedman, SD .
HUMAN GENETICS, 2003, 113 (03) :286-292
[18]   Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population [J].
Wang, XJ ;
Moylan, B ;
Leopold, DA ;
Kim, J ;
Rubenstein, RC ;
Togias, A ;
Proud, D ;
Zeitlin, PL ;
Cutting, GR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (14) :1814-1819
[19]  
Zielenski Julian, 2002, Methods Mol Med, V70, P3